Back to Rankings

IDXX

IDEXX LaboratoriesC
Nasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-18
View Chart
Current thesis
Recurring consumables growth, faster adoption of new diagnostics, and margin expansion push results toward the analyst high; strong execution and stable pricing unlock multiple expansion.
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -6.1.
What can break
Execution failure on product rollouts and slower consumables conversion
Momentum
18
Value
53
Sentiment
71
Setup hits (3d)
— · Net —
AI TargetsBase $766.00 · Bull $892.50 · Bear $479.96
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-02-03 • Model: RankAlpha Sentiment AI
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net —
Target $713.45
Why
Momentum18 · Δ7d +10.0
Value53 · Δ7d -0.1
Sentiment71 · Δ7d -6.1
So what
Balanced signals. Wait for confirmation before sizing up.
Setup hits not loaded

Load setup hits to see net bias and recent triggers.

Load setup hits
Lead driver: Sentiment · See AI snapshot
Momentum
18
26% active weight
Current posture
7d trendImproving
Δ7d
+10.0
Δ21d
-3.0
Value
53
39% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
+0.3
Sentiment
71
34% active weight
Current posture
7d trendSoftening
Δ7d
-6.1
Δ21d
-6.0
Why this grade

Composite grade C. Momentum 17.6 / Value 53.3 / Sentiment 70.8

Fundamentals (TTM)
As of 2026-07-17
Market Cap
$44.76B
Beta
1.67
Shares Out
78.88M
P/E (TTM)
54.1
P/S (TTM)
13.07
P/FCF (TTM)
57.94
Rev YoY
+14.3%
EPS YoY
+17.3%
Gross Margin
+62.1%
Op Margin
+31.3%
Net Debt
$795.99M
Current Ratio
1.06
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology
    IDXX - IDEXX Laboratories - Grade C - RankAlpha